Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers

Vivian Wai Yan Lui(Chinese University of Hong Kong), Jennifer R. Grandis(University of California, San Francisco), Gordon B. Mills(The University of Texas MD Anderson Cancer Center), Bhavana S. Vangara(The University of Texas MD Anderson Cancer Center), Tomoko Nukui(University of Pittsburgh), Matthew L. Hedberg(Carnegie Mellon University), Yiling Lu(The University of Texas MD Anderson Cancer Center), Noah D. Peyser(University of California, San Francisco), Sam Sauerwein(The University of Texas MD Anderson Cancer Center), Umamaheswar Duvvuri(City University of New York), Levi A. Garraway(Broad Institute), Raja S. Seethala(University of Pittsburgh), Marjorie Romkes(University of Pittsburgh), Simion I. Chiosea(University of Pittsburgh), Breean R. Gilbert(The University of Texas MD Anderson Cancer Center), Yan Zeng(The University of Texas MD Anderson Cancer Center), Patrick Kwok‐Shing Ng(The University of Texas MD Anderson Cancer Center), Robert L. Ferris(University of Pittsburgh), Brenda Diergaarde(University of Pittsburgh), Hua Li(Jiading District Central Hospital), Lin Wang(Heilongjiang University), Qiuhong Zhang(The University of Texas MD Anderson Cancer Center), Dong Xiao(Second Affiliated Hospital of Guangzhou Medical University), Seungwon Kim(UPMC Hillman Cancer Center), Yu Du(The University of Texas MD Anderson Cancer Center), Kelsey Pendleton(The University of Texas MD Anderson Cancer Center), Jonas T. Johnson(University of Pittsburgh), Maria L. Freilino(The University of Texas MD Anderson Cancer Center), Peter S. Hammerman(Broad Institute)
Cancer Discovery
April 25, 2013
Cited by 590


Related Papers